Edelman, Steven V.
14 papers on CoChatORCID 0000-0002-0760-9332
Most cited papers
- Verified
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation
Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular and exercise physiology
Cited by 930
- Verified
Impaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1992) · Diabetes
Diabetes, Cardiovascular Risks, and LipoproteinsMetabolism, Diabetes, and Cancer
Cited by 470
- Verified
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Klonoff, D. C., Wang, J., Rodbard, D., Kohn, M. A., Li, C., Liepmann, D., Kerr, D., Ahn, D., Peters, A. L., Umpierrez, G. E., et al. (2023) · Journal of Diabetes Science and Technology
Diabetes Management and ResearchDiabetes Management and Education
Cited by 295
- Verified
Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014
Carls, G., Huynh, J., Tuttle, E., Yee, J., & Edelman, S. V. (2017) · Diabetes Therapy
Diabetes Management and ResearchDiabetes Management and Education
Cited by 228
- Verified
Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic Marker
Buse, J. B., Freeman, J. L. R., Edelman, S. V., Jovanovic, L., & McGill, J. B. (2003) · Diabetes Technology & Therapeutics
Diabetes Management and ResearchAdvanced Glycation End Products research
Cited by 187
- Verified
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes
Carls, G. S., Tuttle, E., Tan, R.-D., Huynh, J., Yee, J., Edelman, S. V., & Polonsky, W. H. (2017) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 153
- Verified
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
Groop, P.-H., Dandona, P., Phillip, M., Gillard, P., Edelman, S., Jendle, J., Xu, J., Scheerer, M. F., Thoren, F., Iqbal, N., et al. (2020) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 79
- Verified
The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures
Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care
Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 70
- Verified
Regulation Catches Up to Reality: Nonadjunctive Use of Continuous Glucose Monitoring Data
Edelman, S. V. (2017) · Journal of Diabetes Science and Technology
Diabetes Management and ResearchHealthcare Regulation
Cited by 51
- Verified
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial
Knowler, W. C., Doherty, L., Edelstein, S. L., Bennett, P. H., Dabelea, D., Hoskin, M., Kahn, S. E., Kalyani, R. R., Kim, C., Pi-Sunyer, F. X., et al. (2025) · The Lancet Diabetes & Endocrinology
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 39
- Verified
The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 29
- Verified
Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement
Kalyani, R. R., Allende-Vigo, M. Z., Antinori-Lent, K. J., Close, K. L., Das, S. R., Deroze, P., Edelman, S. V., El Sayed, N. A., Kerr, D., Neumiller, J. J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism
Diabetes Management and EducationDiabetes Management and Research
Cited by 25
- Verified
Intensive glycemic control improves long-term renal outcomes in type 2 diabetes in the Veterans Affairs Diabetes Trial (VADT)
Agrawal, L., Azad, N., Bahn, G. D., Reaven, P. D., Hayward, R. A., Reda, D. J., Emanuele, N. V., VADT Study Group, Abraira, C., Duckworth, W. C., et al. (2019) · Diabetes Care
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 20
- Verified
Comparison of second-generation basal insulin analogs: A review of the evidence from continuous glucose monitoring
Battelino, T., Edelman, S. V., Nishimura, R., & Bergenstal, R. M. (2021) · Diabetes Technology & Therapeutics
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free